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Abstract
Background: Bipolar disorder (BD) patients have been reported to be associated higher creativity abilities, and recent data tend to support the hypothesis that 
dopaminergic system that could be associated with creativity. Catechol-O-methyltransferase (COMT) is one of the major enzymes involved in the metabolic 
degradation of dopamine. The COMT gene polymorphism (rs4680 or Val158Met) Met allele is reported to cause decreased activity of this enzyme in prefrontal 
cortex and improve performance in several cognitive domains. Objective: The objective of this study was to evaluate the influence of Val158Met on creativity 
in BD type I and healthy controls. Methods: Ninety-seven healthy volunteers and 120 BD type I were genotyped for COMT rs4680 and tested for creativity 
(Barrow Welsh Art Scale – BWAS) and intelligence Wechsler Abbreviated Scale of Intelligence (WASI). Results: COMT Met allele positively influenced 
creativity scores in healthy controls but not in BD subjects during mood episodes and euthymia. The presence of allele Met did not influence IQ scores. No 
influence of IQ total score on creativity was observed. Limitations: control group presented higher IQ scores and euthymic group was under medication 
use. Discussion: Our research suggests positive effect of COMT rs4680 (allele Met) on creativity scores in healthy controls. One possible interpretation is 
that creativity is more likely to be associated with lesser degrees of bipolarity. The fact that the same results were not observed in BD may be associated to 
dysfunctions in the dopaminergic system that characterizes this disorder. Further studies with larger samples and other types of BD should explore the role 
of the dopaminergic system in creativity.
Soeiro-de-Souza MG / Rev Psiq Clín. 2014;41(2):29-33
Keywords: Dopamine, creativity, catechol-O-methyltransferase, bipolar disorder, mania, depression.
Resumo
Contexto: O transtorno bipolar (TB) geralmente é associado a pessoas com maiores habilidades criativas, e dados recentes apontam que o sistema dopaminér-
gico pode estar relacionado à criatividade. A enzima catecol-O-metiltransferase (COMT) é um dos principais agentes envolvidos na degradação metabólica da 
dopamina. O gene da COMT apresenta um polimorfismo (rs4680 ou Val158Met) no qual o alelo Met se associa a uma diminuição da atividade enzimática da 
COMT, levando a um melhor desempenho em testes cognitivos. Objetivo: O objetivo deste estudo foi avaliar a influência do polimorfismo funcional Val158Met 
na criatividade de pacientes com TB e em controles. Métodos: Noventa e sete voluntários saudáveis e 120 pacientes com TB tipo I foram genotipados para 
COMT rs4680 e testados para criatividade (Barrow Welsh Art Scale – BWAS) e inteligência (Wechsler Abbreviated Scale of Intelligence – WASI). Resultados: 
O alelo Met da COMT associou-se a maiores pontuações na escala de criatividade na amostra de controles saudáveis, mas o mesmo não foi observado em 
pacientes com TB. A presença do alelo Met não influenciou a pontuação de QI em nenhum dos grupos. O grupo controle apresentava QI médio maior que 
o grupo TB; o grupo TB estava em uso de múltiplas medicações no momento das avaliações. Conclusão: Nossos resultados sugerem influência positiva do 
alelo Met do COMT rs4680 na criatividade de controles saudáveis. Isso sugere que a criatividade seja uma função possivelmente associada a menores graus 
de bipolaridade do que nos pacientes com TB tipo I. O fato de não termos observado influência do alelo Met nos resultados dos pacientes com TB pode ser 
justificado pelo fato de que justamente alterações nesse sistema sejam uma das características básicas do TB. É necessário maior número de estudos com 
maiores tamanhos amostrais para explorar mais detalhadamente o papel do sistema dopaminérgico na criatividade.
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Introduction
Bipolar disorder (BD), especially in its softer expressions1,2, is 
associated with professional success and increased creativity3. 
Although Jamison3 contends that the relationship between creativity 
and BD may be at the trait or temperament level4 and it is influenced 
by cognitive function and symptoms5. Little is known about the 
biological underpinnings of creativity in BD, although psychological, 
neuropsychological and functional imaging studies in healthy 
subjects have indicated the potential role of the dopaminergic 
system6-9. 
Dopaminergic pathways project into numerous brain areas 
implicated in the pathophysiology of BD10. Historically, dopaminergic 
models of BD have been dichotomous and support both dopamine 
(DA) excess in mania and deficiency in depression11. However, most 
30 Soeiro-de-Souza MG / Rev Psiq Clín. 2014;41(2):29-33
of these models were conceptualized based on indirect evidence 
drawn from pharmacological and animal studies10. DA has been 
strongly implicated in motivation and reward systems12. Moreover, 
high DA has been reported to decrease inhibition of incoming 
stimuli from the surrounding environment13,14, a trait characteristic 
of creative individuals of higher intelligence15. Also, the ability 
to generate many different ideas about a topic in a short period 
(divergent thinking), a key aspect of creativity16, is present in mania 
and influenced by dopaminergic function. Furthermore, a recent 
study has reported an association between divergent thinking and 
DA receptor polymorphisms17. 
Catechol-O-methyltransferase (COMT) is one of the main 
enzymes involved in the catabolism of DA18 and thus constitutes 
an important regulator of prefrontal cortical (PFC) dopaminergic 
levels19. The COMT gene single nucleotide polymorphism (SNP) 
rs4680 (also known as Val158Met) leads to a 35% to 50% reduction 
in the COMT enzyme in Met allele carriers (Met+)18. COMT SNP 
rs4680 Met+ has been linked to better performance on cognitive 
tests20-23 probably to an increment in PFC DA due to lower COMT 
activity. To our knowledge, only one study has investigated the 
association of COMT and creativity in healthy controls, and reported 
negative results17. 
The objective of this research was to investigate the role of 
COMT functional polymorphism Val158Met in creativity scores of 
healthy controls, and BD patients in euthymia and during mood 
episodes. We hypothesized that carriers of the Met allele would have 
higher creativity scores than Met non-carriers due to lower COMT 
activity in the PFC.
Material and methods
Subjects
The patients sample comprised one-hundred-nineteen individuals 
with BD I, aged between 18 and 40 years old in euthymia (N = 
42), manic (N = 44) or depressive (N = 33) episode according to 
DSM-IV TR criteria24. In the euthymic group 78.6% were using 
lithium, 52.4% were using anticonvulsants, 23.8% were using second 
generation antypsychotics, 16.7% were using antidepressants and 
4.8% were using benzodiazepines ate the time of neuropsychological 
evaluation. Patients experiencing mood episodes were medication 
free. They were participants in the LICAVAL clinical trial25 and 
were evaluated immediately after a wash-out period of four weeks 
for antidepressants, mood stabilizers and antipsychotics, or of eight 
weeks for depot medications. Diagnosis were determined by trained 
psychiatrists using the Structured Clinical Interview (SCID-I)26 
for DSM-IV TR24. The Young Mania Rating Scale (YMRS)27, and 
the Montgomery-Asberg Depression Rating Scale (MADRS)28 
were used to evaluate the intensity of symptoms. Subjects with 
neurological disorders, previous head trauma, any illness requiring 
medical intervention, currently substance abuse, or who had 
undergone electroconvulsive therapy in the preceding six months, 
were excluded.
Ninety-seven healthy subjects, age 18-35 years, were recruited at 
the University of São Paulo (mostly medical students) to our controls 
group. Inclusion criteria were no psychiatric diagnosis (present or 
past) according to the evaluation by trained psychiatrists using The 
Mini International Neuropsychiatric Interview (M.I.N.I.)29, negative 
family history of mood or psychotic disorders (first degree), no use 
of any psychopharmacological agent, and no substance abuse over 
the last three months.
Creativity and intelligence assessment 
Creativity test was out under standard conditions and scored by 
two trained neuropsychologists. Since it is known that intelligence 
and creativity are reported to be correlated (up to r = 0.50)30, it was 
necessary to rule out the possibility that significant associations 
between creativity and polymorphisms might merely reflected a 
relationship to intelligence. Intelligence Quotient (IQ) was assessed 
using the Wechsler Abbreviated Scale of Intelligence (WASI)31. 
Creativity was assessed using the Barrow Welsh Art Scale (BWAS). 
The BWAS32 is an empirically derived metric consisting of 86 
black and white images that individuals rate as “like” or “dislike”, 
with higher scores reflecting preference for more asymmetrical 
and complex figures over more symmetrical and simple figures. 
Preference for more asymmetrical and complex figures is higher 
among artists than non-artists according to BWAS scores33. The 
BWAS scale could also reflect cognitive/affective contributions to 
creativity, as it involves not only visual processing, but also affective 
processing (“like” or “dislike”). Indeed, BWAS scores have been 
linked not only to creativity measured by other means but also to 
emotionality34.
Genotyping 
DNA was extracted from peripheral blood according to the 
salting-out protocol35 and genotyped for COMT rs4680 using real-
time PCR allelic discrimination. PCR amplification for rs4680 was 
performed in 5 μl reactions with 5 ng of template DNA, 1× TaqMan 
Universal Master Mix (Applied Biosystems, Foster City, CA), 1× 
each primer and probe assay, and H2O. Thermal cycling consisted 
of first denaturation for 10 min at 95 °C, followed by 40 cycles of 
denaturation at 95 °C for 15 s and annealing at 60 °C for 1 min. The 
allele-detection process and allelic discrimination were performed 
for 1 min at 60 °C on a 7500 Real-Time System (Applied Biosystems, 
Foster City, CA). Quality control of Real time PCR results was done 
by direct sequencing on a ABI PRISM® 3100 Genetic Analyzer 
(Applied Biosystems, Foster City, CA).
Statistical analysis
Groups of subjects were classified into four groups (euthymia, 
mania, depression and controls). Chi-square test was used for 
comparison of categorical data, and the ANOVA for continuous 
data. Turkey test was used for multivariable bias correction. BWAS 
total score was entered as a dependent variable in a MANOVA 
model using age, gender, education, rs4680 allele Met and WASI-
IQ as covariates. The MANOVA model was separately tested in 
each of the four groups to test the effect of covariates in BWAS. 
The PASW statistics version 19.0 software (SPSS Inc., Chicago, 
Illinois) was used for all analyses. 
Ethics
The research ethics board of Hospital das Clínicas of the University 
of São Paulo approved the study. Written informed consent was 
obtained from all subjects.
Results
The COMT genotype distribution in the experimental was in 
accordance with the Hardy-Weinberg equilibrium (χ2 = 0.79 p = 0.56) 
indicating that the samples were representative. Allelic distribution 
in the sample was 49.1% for allele Val and 50.8% for allele Met. 
Sociodemographic data of all four groups is presented in table 1. 
Univariate analysis of variance (MANOVA) in which the total 
score BWAS was entered as a dependent variable and age, gender, 
education, rs4680 allele Met and WASI-IQ as covariates revealed 
an influence of age (B = -0.84 p = 0.05) and allele Met (B = 7.05 
p = 0.03) in BWAS score in healthy controls (Table 2). No influence 
of gender, education or IQ in BWAS was observed in controls. 
The same MANOVA model in mania group revealed that gender 
influenced BWAS score (B = 9.8 p = 0.02). Females in the manic 
group presented higher creativity scores. In the same manic group a 
trend was observed for the influence of allele Met on BWAS scores 
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Table 1. Comparison of sociodemographic characteristics, WASI-IQ, BWAS scores and allele Met prevalence in controls, euthymia, mania 
and depression groups
Gender (female/male) Age Education WASI-IQ BWAS allele Met (Met+/Met-)
Controls (N = 97) 52/45 74/23
Mean 24.3 13.9 110.5 24.1
Std. Deviation 4.7 2.4 16.0 13.1
Euthymia (N = 42) 27/15 33/19
Mean 32.9 12.6 99.3 27.3
Std. Deviation 10.9 3.1 12.9 12.0
Mania (N = 44) 35/9 29/15
Mean 29.3 12.2 95.2 25.3
Std. Deviation 5.3 3.5 14.1 11.4
Depression (N = 33) 18/15 20/13
Mean 26.9 12.6 97.3 17.3
Std. Deviation 5.2 2.4 12.3 10.4
ANOVA
F 18.5 4.3 15 3.8
Sig < 0.001 0.006 < 0.001 0.01
Turkey M>D<E>C M=D=E<C M=D=E<C M>D<E>C
Chi-Squared 0.02 0.14
Significance level p < 0.05.
Table 2. MANOVA model: BWAS total score was entered as a dependent variable and age, gender, education, rs4680 allele Met and 
WASI-IQ were entered as covariates
Dependent Variable: BWAS
Parameter B Std. Error t Sig. Partial Eta Squared Observed Power
Controls
(N = 97) Age -0.84 0.42 -2.01 0.05 5% 51%
Gender -4.01 2.74 -1.46 0.15 3% 30%
Education 0.60 0.60 1.00 0.32 1% 17%
rs4680 allele Met 7.05 3.12 2.26 0.03 6% 61%
WASI-IQ -0.05 0.11 -0.50 0.62 0% 8%
Mania
(N = 44) Age 0.07 0.31 0.22 0.83 0% 6%
Gender 9.86 4.10 2.40 0.02 14% 65%
Education -0.49 0.54 -0.90 0.37 2% 14%
rs4680 allele Met -6.40 3.58 -1.79 0.08 8% 41%
WASI-IQ 0.02 0.14 0.13 0.89 0% 5%
Depression
(N = 33) Age -0.06 0.41 -0.15 0.88 0% 5%
Gender -1.99 4.30 -0.46 0.65 1% 7%
Education -1.29 0.95 -1.35 0.19 8% 25%
rs4680 allele Met 6.74 4.48 1.51 0.15 10% 30%
WASI-IQ 0.08 0.19 0.43 0.67 1% 7%
Euthymia Age 0.08 0.21 0.39 0.70 1% 7%
(N = 42) Gender 1.74 4.93 0.35 0.73 0% 6%
Education -0.25 0.84 -0.30 0.77 0% 6%
rs4680 allele Met -0.22 7.17 -0.03 0.98 0% 5%
WASI-IQ 0.19 0.20 0.93 0.36 3% 15%
(B = -6.4 p = 0.08). No influence of age, education or IQ on BWAS 
total score was observed on the manic group.
In the depression and euthymic groups the same MANOVA 
model revealed that none of the covariates influenced BWAS total 
score (Table 2).
Discussion
This is the first study investigating the role of COMT Val158Met in 
creativity output in bipolar I disorder. Moreover, this is also the 
first study to report a positive association between COMT rs4680, 
specifically allele Met, and higher scores on the BWAS in the healthy 
population. Carriers of allele Met present lower COMT enzyme 
activity in PFC18,19, and in the present study this same group was 
shown to have higher BWAS scores in the healthy control group. This 
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finding confirms the recent hypothesis that COMT numbers among 
the candidate genes for creativity17. In the other hand, in BD the Met 
allele did not influence creativity in mood episodes or euthymia.
These findings reinforce the putative role of DA in creative 
abilities hypothesized based on pharmacological studies. In 
Parkinson’s disease (PD), the emergence of poetic talent36 and 
“compulsive” augmentation of artistic productivity37 have been 
reported in dopaminergic replacement therapy36. Furthermore, DA 
antagonists, such as typical antipsychotics, are reported to suppress 
creativity38. Functional imaging studies have shown that the creative 
thinking process is associated with increased PFC activity8,39. These 
reports are consistent with findings of reviews of creativity studies 
suggesting that the dopaminergic system, including the PFC, is 
associated with creativity8,40. Also, results of studies on COMT 
functional SNPs and the differential effects of D1 and D2 receptor 
binding, have clarified this association. The allele Met, associated 
with low-activity COMT, has been theoretically linked to decreases 
in phasic and increases in tonic DA transmission subcortically, and 
in increases DA concentrations cortically. This is associated with 
increased D1 and decreased D2 transmission in the PFC41, which 
have in turn been associated with higher creative achievement or 
psychosis15. Moreover this same SNP have been reported to modulate 
cognitive function in BD during mood episodes42.
Dopaminergic and other transmitter relationships to creativity 
have also been suggested in studies involving non-bipolar patients. 
A recent study reported an association between divergent thinking 
and dopamine receptor polymorphism. Higher creativity scores 
were observed in carriers of the A1 allele17. The A1 allele of 
DRD2 (rs1800497) has a 30%-40% reduction in DA-D2 receptor 
density43. In the same study, these authors reported that carriers 
of the A allele of the serotonin polymorphism TPH1 A779C also 
had higher creativity scores17. In another study involving a sample 
of healthy subjects, Kéri studied a polymorphism in the promoter 
region of neuregulin 1 and found that the T allele was associated with 
higher creative scores44. Thus, further examination of the possible 
neurobiological underpinnings of the link between bipolar disorder 
and creativity are warranted, especially in those with lesser degrees 
of bipolarity at the trait level. Dopaminergic function should be 
investigated in cyclothymic and related temperaments, which the 
work of Akiskal et al. well as supportive evidence from Stanford45, 
and supportive evidence from Italian work46, suggest might be an 
underlying ingredient in creative work4. Andreasen and Canter’s 
early work had also implicated cyclothymic tendencies or disorder47.
Andreasen and Powers’ work also raised the possibility 
that over-inclusive thinking is characteristic for both mania and 
schizophrenia48. In bipolar disorder the thought processes are less 
extreme than in schizophrenia and might even be somewhat different 
qualitatively, and it may be that the overall thought impairment 
characteristic of schizophrenia restricts the execution of creativity. 
There are many difficulties inherent to systematic studies of 
creativity, particularly methodological problems concerning the 
reliability and validity of creativity measures, and disagreements 
over the definition of creativity. The BWAS is not the only measure 
of creativity and other measures should be explored before drawing 
more definitive conclusions. In the present study, it was decided to 
examine the correlation between scores on a widely used scale for 
measuring creativity and the presence of functional polymorphism 
of COMT (rs4680), which likely influences PFC cognition, in a 
homogeneous sample of university students. Our results are also 
consistent with those reported in the literature investigating the 
role of DA and COMT in PFC function and cognition. However, no 
influence of COMT on IQ was evident, and BWAS and IQ scores 
were unrelated, further suggesting some degree of specificity in the 
association of COMT with creativity.
This study is the first to report findings that suggest the effects 
of COMT gene polymorphism may not be limited to isolated basal 
cognitive abilities, but could partially account for greater cognitive 
abilities related to creativity in healthy controls. In the other hand, 
we found evidence that creativity during BD episodes and euthymia 
is not associated with COMT DA catabolism activity in the PFC. 
Further studies involving larger samples should be conducted in 
an effort to replicate our findings. In addition, given the strong and 
consistent body of evidence indicating an association of bipolar 
spectrum disorders with creativity1,4,46, examining the association 
of COMT polymorphism with creativity in this population is now 
warranted. 
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